COVID 19 - Clinical Picture in the Elderly Population: A Qualitative Systematic Review
Neumann-Podczaska Agnieszka, Al-Saad Salwan R, Karbowski Lukasz M, Chojnicki Michal, Tobis Slawomir, Wieczorowska-Tobis Katarzyna
Table 4
Summary Table.
No. Studies with reported results
Total patients
Symptoms
16
1285
No. Patients
%
Fever
1074/1285
83.6
Cough
806/1285
62.7
Dyspnea
328/1285
25.5
Fatigue
256/1285
19.9
Sputum Production
227/1285
17.7
Chest Tightness
196/1285
15.3
Diarrhea
167/1285
13.0
Anorexia
108/1285
8.4
Fatigue & Myalgia
103/1285
8.0
Myalgia
59/1285
4.6
Nausea & Vomiting
57/1285
4.4
Others
*
265/1285
20.6
Comorbidities
16
2288
No. Patients
%
Hypertension
979/2288
42.8
Cardiovascular Disease
517/2288
22.6
Diabetes
395/2288
17.3
Chronic Lung Disease
188/2288
8.2
Hypercholesterolemia
156/2288
6.8
Malignancy (Active or in Remission)
108/2288
4.7
Chronic Renal Disease
83/2288
3.6
Cerebrovascular Disease
54/2288
2.4
Chronic Hepatic Disease
38/2288
1.7
Not Specified
145/2288
6.3
Others
**
156/2288
6.8
Radiological Findings
9
402
Description
No. Patients
%
Ground Glass Opacity (GGO)
115/402
28.6
GGO + Consolidations
52/402
12.9
Pleural effusion
15/402
3.7
Consolidations
18/402
4.5
Normal
11/402
2.7
Distribution
Multiple Lobes
250/402
62.2
Single Lobe
4/402
1.0
Not Specified
148/402
36.8
Bilateral
234/402
58.2
Unilateral
32/402
8.0
Not Specified
136/402
33.8
Peripheral
18/402
4.5
Peripheral + Central
10/402
2.5
Central
0/402
0.0
Not Specified
374/402
93.0
Outcome
14
4531
No. Patients
%
Hospitalized (
As of date of publication)
2290/4531
50.5
Discharged
1203/4531
26.6
Death
907/4531
20.0
Not Specified
131/4531
2.9
Complications
9
3241
No. Patients
%
Renal Impairment/ Injury
832/3241
25.7
Secondary Infection
160/3241
4.9
Hepatic Impairment/ Injury
147/3241
4.5
ARDS
126/3241
3.9
Acute Heart Injury
79/3241
2.4
Cardiac insufficiency
59/3241
1.8
Arrhythmia
35/3241
1.1
Others
+
57/3241
1.8
Treatment (drugs)
9
476
No. Patients
%
Antiviral Therapy
++
330/476
69.3
Antibiotic Therapy-
199/476
41.8
Immunoglobulin
134/476
28.2
Glucocorticoids
107/476
22.5
Interferon
98/476
20.6
Lopinavir & Ritonavir
61/476
12.8
Umifenovir
49/476
10.3
Oseltamivir
5/476
1.1
Ribavirin
4/476
0.8
Supplementary Oxygen
9
1424
1020/1424
71.4
Treatment (Mechanical Ventilation)
10
4018
No. Patients
%
Invasive MV
1344/4018
33.4
Non-Invasive MV
96/4018
2.4
MV - Not specified
30/4018
0.7